Neurogene is focused on developing life-changing genetic medicines for patients families affected by rare, devastating neurological diseases... NEW YORK --(BUSINESS WIRE)--Feb. 29, 2024-- Neurogene Inc. (NASDAQ: NGNE) ("Neurogene" or "the Company"),..
Relevance: 78.35815